Concord Drugs Fundamentals
P/E Ratio
103.06
P/B Ratio
2.24
Div. Yield
0
Sector P/E
69.94
Sector P/B
2.97
Sec. Div. Yield
0.55
Concord Drugs Fundamentals is currently trading with a P/E Ratio of 103.06, compared to the sector average of 69.94. Its P/B Ratio stands at 2.24, while the sector’s is 2.97. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.55%.
Concord Drugs Score Card
Price
Expensive
Growth
Good
Quality
Poor
Management
Poor
On its scorecard, Concord Drugs reflects: Price – Expensive, Growth – Good, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.
